Biktarvy, formally known as biktarvy, is a powerful single-tablet therapy for controlling HIV infection. This medication unites three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the virus's ability to copy within the body, remarkably reducing the viral burden. For many individuals, Biktarvy